Tulane Ventures has invested $125,000 in Beken Bio, a biotechnology startup developing early-detection blood tests for aggressive cancers, bringing the company’s founder back to New Orleans as it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results